Literature DB >> 11846306

Fatal warm autoimmune hemolytic anemia resulting from IgM autoagglutinins in an infant with severe combined immunodeficiency.

A Nowak-Wegrzyn1, K E King, R S Shirey, A R Chen, C McDonough, H M Lederman.   

Abstract

Autoimmune diseases are rare in patients with severe combined immunodeficiency (SCID). The authors describe an 11-month-old infant girl with SCID with fatal warm autoimmune hemolytic anemia (AIHA) resulting from IgM autoagglutinins. Serologic evaluation revealed IgM autoantibodies that caused in vitro hemagglutination at 37 degrees C. The patient had clinical evidence of ongoing hemolysis and agglutination despite aggressive treatment. She had three strokes and died 6 weeks after unsuccessful bone marrow transplantation. Autoimmune disease is an unexpected complication of SCID. The presence of warm reactive IgM autoagglutinins in AIHA confers a dismal prognosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11846306     DOI: 10.1097/00043426-200105000-00015

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

Review 1.  Treatment with rituximab in benign and malignant hematologic disorders in children.

Authors:  Lisa B Giulino; James B Bussel; Ellis J Neufeld
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

2.  Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab.

Authors:  Mark P Chao; Jison Hong; Christian Kunder; Laura Lester; Stanley L Schrier; Ravindra Majeti
Journal:  Am J Hematol       Date:  2014-07-11       Impact factor: 10.047

3.  High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases.

Authors:  C H McDonough; D A Jacobsohn; G B Vogelsang; S J Noga; A R Chen
Journal:  Bone Marrow Transplant       Date:  2003-06       Impact factor: 5.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.